Study summary · research use only
Thymosin alpha 1: A comprehensive review of the literature
Plain-language summary
Paraphrased from the published abstract below — not a verdict on whether anything works.
This review describes thymosin alpha 1, a peptide naturally occurring in the thymus, as having roles in modifying, enhancing, and restoring immune function. The authors describe its use in immunocompromised states and malignancies, as a vaccine-response enhancer, and in sepsis and infections. The review discusses studies proposing that thymosin alpha 1 could influence outcomes in severely ill coronavirus disease 2019 patients by addressing lymphocytic immune overactivation and by limiting excessive T cell activation. The authors summarize literature on the background and clinical uses of thymosin alpha 1 and describe its antibacterial and antiviral properties, stating they believe further investigation of thymosin alpha 1's antiviral properties and potential use against severe acute respiratory syndrome coronavirus-2 is warranted.
Abstract
Thymosin alpha 1 is a peptide naturally occurring in the thymus that has long been recognized for modifying, enhancing, and restoring immune function. Thymosin alpha 1 has been utilized in the treatment of immunocompromised states and malignancies, as an enhancer of vaccine response, and as a means of curbing morbidity and mortality in sepsis and numerous infections. Studies have postulated that thymosin alpha 1 could help improve the outcome in severely ill corona virus disease 2019 patients by repairing damage caused by overactivation of lymphocytic immunity and how thymosin alpha 1 could prevent the excessive activation of T cells. In this review, we discuss key literature on the background knowledge and current clinical uses of thymosin alpha 1. Considering the known biochemical properties including antibacterial and antiviral properties, time-honored applications, and the new promising findings regarding the use of thymosin, we believe that thymosin alpha 1 deserves further investigation into its antiviral properties and possible repurposing as a treatment against severe acute respiratory syndrome coronavirus-2.
pepmg summarizes the peer-reviewed literature and links to every source — it sells nothing, ships nothing, and gives no medical, dosing, or human-use guidance. Don't just trust this summary: follow the citation to its source and read it yourself. Research use only.